{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:01:33Z","timestamp":1792047693591,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3402100"],"award-info":[{"award-number":["2023YFC3402100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2024AFD426"],"award-info":[{"award-number":["2024AFD426"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574250"],"award-info":[{"award-number":["82574250"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504200"],"award-info":[{"award-number":["82504200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017958","name":"Health Commission of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118569","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:07:51Z","timestamp":1768262871000},"page":"118569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of WWZ-11-098: a rigid and selective CDK6 degrader"],"prefix":"10.1016","volume":"305","author":[{"given":"Wanwan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangqiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6796-9500","authenticated-orcid":false,"given":"Baishan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118569_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.118569_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/j.seminoncol.2015.09.024","article-title":"Targeting cyclin-dependent kinases and cell cycle progression in human cancers","volume":"42","author":"Santo","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejmech.2026.118569_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s12276-025-01395-3","article-title":"Targeting CDK4\/6 in breast cancer","volume":"57","author":"Shanabag","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118569_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/14728222.2023.2285775","article-title":"CDK6: an attractive therapeutic target for T-ALL\/LBL","volume":"27","author":"Li","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2026.118569_bib5","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.18632\/oncotarget.9965","article-title":"An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia","volume":"7","author":"Lopez","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2026.118569_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2014-02-558114","article-title":"Requirement for CDK6 in MLL-rearranged acute myeloid leukemia","volume":"124","author":"Placke","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.118569_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ccell.2025.02.006","article-title":"CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety","volume":"43","author":"Palmer","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.118569_bib8","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.SABCS24-P4-10-06","article-title":"Abstract P4-10-06: preclinical characterization of BGB-43395, a potential best-in-class CDK4 selective inhibitor with potent pharmacodynamic and anti-tumor activity in HR+HER2- breast cancer models","volume":"31","author":"Zhu","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118569_bib9","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1021\/acs.jmedchem.2c00397","article-title":"Selectivity through targeted protein degradation (TPD): miniperspective","volume":"65","author":"Gopalsamy","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118569_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118569_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.chembiol.2018.11.006","article-title":"Homolog-selective degradation as a strategy to probe the function of CDK6 in AML","volume":"26","author":"Brand","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118569_bib12","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1021\/acs.jmedchem.9b00871","article-title":"Potent and preferential degradation of CDK6 via proteolysis targeting chimera degraders","volume":"62","author":"Su","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118569_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41467-022-28515-1","article-title":"Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma","volume":"13","author":"Ng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118569_bib14","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bmcl.2019.03.035","article-title":"Selective degradation of CDK6 by a palbociclib based PROTAC","volume":"29","author":"Rana","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118569_bib15","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1039\/D0SC00167H","article-title":"Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders","volume":"11","author":"Steinebach","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.118569_bib16","article-title":"INK4 tumor suppressor proteins mediate resistance to CDK4\/6 kinase inhibitors","author":"Li","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.118569_bib17","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1002\/anie.201901336","article-title":"Development of dual and selective degraders of cyclin-dependent kinases 4 and 6","volume":"58","author":"Jiang","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118569_bib18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood.2019003604","article-title":"Selective inhibition of ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs","volume":"135","author":"De Dominici","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.118569_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41570-025-00784-6","article-title":"Lessons learned in linking PROTACs from discovery to the clinic","author":"Pike","year":"2025","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.ejmech.2026.118569_bib20","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.2c01864","article-title":"Catalytic degraders effectively address kinase site mutations in EML4-ALK oncogenic fusions","author":"Gao","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118569_bib21","series-title":"CDK Inhibitor and Polymorph of Phosphate Thereof","author":"Chen","year":"2024"},{"key":"10.1016\/j.ejmech.2026.118569_bib22","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c00965","article-title":"Development of degraders of cyclin-dependent kinases 4 and 6 based on rational drug design","author":"He","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118569_bib23","doi-asserted-by":"crossref","first-page":"9056","DOI":"10.1021\/acs.jmedchem.1c00159","article-title":"Discovery of PF-06873600, a CDK2\/4\/6 inhibitor for the treatment of cancer","volume":"64","author":"Freeman-Cook","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118569_bib24","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c00965","article-title":"Development of degraders of cyclin-dependent kinases 4 and 6 based on rational drug design","author":"He","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118569_bib25","article-title":"CDK inhibitors and their use as pharmaceuticals","author":"Wu","year":"2024","journal-title":"WO 2024216249"},{"key":"10.1016\/j.ejmech.2026.118569_bib26","series-title":"CDK2\/4\/6 Inhibitor, Preparation Method Therefor, and Application Therof","author":"Zhang","year":"2022"},{"key":"10.1016\/j.ejmech.2026.118569_bib27","volume":"WO 2020224568","author":"Hu","year":"2020"},{"key":"10.1016\/j.ejmech.2026.118569_bib28","article-title":"Heterocyclic compound having cyclin-dependent kinase inhibitory activity, preparation method therefor and medical use thereof","author":"Yan","year":"2023","journal-title":"WO 2023051302"},{"key":"10.1016\/j.ejmech.2026.118569_bib29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41589-021-00765-y","article-title":"Discovery and resistance mechanism of a selective CDK12 degrader","volume":"17","author":"Jiang","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118569_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature22797","article-title":"The metabolic function of cyclin D3\u2013CDK6 kinase in cancer cell survival","volume":"546","author":"Wang","year":"2017","journal-title":"Nature"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T01:09:10Z","timestamp":1773536950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"alternative-id":["S0223523426000140"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118569","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of WWZ-11-098: a rigid and selective CDK6 degrader","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118569"}}